At CellMosaic®, we’re committed to empowering researchers with high-quality, innovative, and advanced bioconjugates—making cutting-edge science more accessible than ever. Whether you need premium reagents and ready-to-use kits (PerKit®) or expert support in developing bioconjugate drug candidates, detection agents, and research tools, we've got you covered.
We’re thrilled to Announce our newest PerKit® additions:
- CM11435 Antibody or Protein Exatecan Conjugation Kit
- CM11436 Antibody or Protein Exatecan Conjugation Kit with VC-PAB Linker
- CM11438 Antibody or Protein SN38 Conjugation Kit with VC-PAB-Linker
- CM11439 Antibody or Protein PBD Dimer Conjugation Kit
Why It Matters:
CellMosaic’s PerKit® revolutionize research by enabling in-house antibody- and protein-drug conjugation, reducing the time needed to develop complex conjugation processes and reliance on expensive CRO services. With all necessary reagents and protocols included, researchers can easily synthesize drug conjugates using their own antibodies/proteins and standard lab equipment.
Key Benefits:
- Simple and efficient labeling of antibody or protein that minimizes toxin exposure
- Fast preparation: 6 hours total, with less than 2 hours of hands-on time.
- Inclusion of all necessary reagents and supplies for preparation and purification.
- Option to choose tailored post-conjugation services at CellMosaic for Analysis and Drug loading determination
Stay ahead in bioconjugation with PerKit®
-------------------------------------------
About PerKit® Conjugation Kits
Historically, antibody-drug conjugation was conducted primarily by drug developers, sometimes in collaboration with contract research organizations (CROs). However, the high cost of these services often limited research opportunities for academic institutions and small biotech companies.
In December 2017, CellMosaic introduced its first ADC kit product line, empowering researchers to prepare antibody-drug conjugates (ADCs) in-house and significantly reducing reliance on costly CRO services. Each kit includes all necessary reagents and detailed protocols for bioconjugate synthesis, requiring only the customer’s antibody or protein and standard laboratory equipment.
--------------------------------------------
About CellMosaic, Inc.
CellMosaic® Inc. is a Massachusetts-based biotech company dedicated to creating high-quality, innovative, and advanced bioconjugates. Bioconjugates are used broadly as research tools, diagnostic reagents, and a novel modality for drugs. Due to the complexities of the bioconjugation process and requirement of techniques and knowledge across multidisciplinary fields, not many companies are competent to offer high-quality bioconjugation services and to provide high-quality bioconjugates. CellMosaic was established in 2008 to fill this gap and has since spent a lot of research effort on developing innovative linkers, crosslinking technologies, and advanced bioconjugation processes. CellMosaic’s current business is organized into four units: 1) Reagent/kit business commercializing bioconjugate reagents and personalized bioconjugation kits (PerKit®) based on CellMosaic’s advanced bioconjugation processes − many of these PerKits™ are for preparation of advanced bioconjugates by the customer, such as antibody drug conjugates (ADCs), antibody oligo conjugates (AOCs), and single labeled bioconjugates; 2) Custom conjugation services for research bioconjugates; 3) Contract bioconjugate manufacturing focusing on process development, scale-up, and GLP/GMP manufacturing, and 4) AqT® ADC development focusing on licensing and manufacturing next-generation ADCs using super-hydrophilic and high loading AqT® linkers. These four business units complement each other and form an integrated bioconjugation workflow from ideation to commercialization.